当前位置: X-MOL 学术Eur. J. Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2022-06-22 , DOI: 10.1002/ejhf.2587
Wilfried Mullens 1, 2 , Jeroen Dauw 1, 2 , Pieter Martens 1 , Evelyne Meekers 1, 2 , Petra Nijst 1 , Frederik H Verbrugge 3, 4 , Fabien Chenot 5 , Samer Moubayed 6 , Riet Dierckx 7 , Philippe Blouard 8 , David Derthoo 9 , Walter Smolders 10 , Bavo Ector 11 , Michaël Hulselmans 12 , Stijn Lochy 3 , David Raes 13 , Emeline Van Craenenbroeck 14, 15 , Hans Vandekerckhove 16 , Pieter-Jan Hofkens 17 , Kathleen Goossens 18 , Anne-Catherine Pouleur 19 , Michel De Ceuninck 20 , Laurence Gabriel 21 , Philippe Timmermans 22 , Edgard A Prihadi 23 , Frederik Van Durme 24 , Michel Depauw 25 , Delphine Vervloet 26 , Els Viaene 27 , Jean-Luc Vachiery 28 , Katrien Tartaglia 1 , Jozine M Ter Maaten 29 , Liesbeth Bruckers 2 , Walter Droogne 30 , Pierre Troisfontaines 31 , Kevin Damman 29 , Johan Lassus 32 , Alexandre Mebazaa 33 , Gerasimos Filippatos 34 , Frank Ruschitzka 35 , Matthias Dupont 1
Affiliation  

To describe the baseline characteristics of participants in the Acetazolamide in Decompensated Heart Failure with Volume Overload (ADVOR) trial and compare these with other contemporary diuretic trials in acute heart failure (AHF).

中文翻译:

乙酰唑胺治疗失代偿性心力衰竭容量超负荷试验 (ADVOR):基线特征

描述乙酰唑胺在失代偿性心力衰竭伴容量超负荷 (ADVOR) 试验中的基线特征,并将其与其他当代急性心力衰竭 (AHF) 利尿剂试验进行比较。
更新日期:2022-06-22
down
wechat
bug